In this podcast series, DPHARM Directors Valerie Bowling and Tracey Kimball break down what to expect at DPHARM 2025. Part I of this podcast series covers keynotes and key topics for this year's event, including:
- Former Merck CEO, Ken Frazier
- Former Head of FDA, Scott Gottlieb
- CRISPR Gene Therapy Patient Keynote, Victoria Gray
- Tuft's Ken Getz
- How DPHARM is tackling AI
- What to do about Protocol Complexity
- and more
Related Podcasts
View All
How Pharma Is Adopting Generative AI Across Clinical Development
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness
